<DOC>
	<DOCNO>NCT01149369</DOCNO>
	<brief_summary>The principal objective multicenter , randomize , placebo-controlled trial evaluate whether 4 week treatment aprepitant improve nausea compare placebo patient symptoms chronic nausea vomit presume gastric origin .</brief_summary>
	<brief_title>Aprepitant Relief Nausea Patients With Chronic Nausea Vomiting Presumed Gastric Origin Trial</brief_title>
	<detailed_description>APRON multicenter , randomize , double-masked , placebo control trial 4 week treatment aprepitant placebo patient symptoms gastroparesis related disorder . Screening eligibility collection baseline data span 4 week obtain informed consent registration . Eligible patient consist patient symptoms gastroparesis randomize either aprepitant ( 125 mg per day ) placebo 4 week . The symptom measure Gastroparesis Cardinal Symptom Index Daily Diary ( GCSIDD ) one week baseline four week randomization . In addition , nausea symptom measure daily 0 100 mm visual analog scale ( VAS ) 14 one week baseline daily four week randomization . There 2 week washout period end treatment ensure patient safety follow end treatment .</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Gastroparesis</mesh_term>
	<mesh_term>Aprepitant</mesh_term>
	<mesh_term>Fosaprepitant</mesh_term>
	<criteria>Age 18 year old registration Gastric empty scintigraphy within 2 year registration Normal upper endoscopy upper GI series within 2 year registration Symptoms chronic nausea vomit compatible gastroparesis functional gastric disorder least 6 month ( contiguous ) prior registration Gastroparesis Cardinal Symptom Index ( GCSI ) score great equal 21 Significant nausea define visual analog scale ( VAS ) score great equal 25 mm 0 100 mm scale Another active disorder could explain symptoms opinion investigator Use narcotic 3 day per week Significant hepatic injury define significant alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) elevation great 2x upper limit normal ( ULN ) ChildPugh score 10 great Contraindications aprepitant hypersensitivity allergy Concurrent use warfarin , pimozide , terfenadine , astemizole , cisapride Pregnancy nursing Any condition , opinion investigator would impede compliance hinder completion study Failure give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>gastroparesis</keyword>
	<keyword>nausea</keyword>
	<keyword>vomit</keyword>
</DOC>